NO950360L - Nytt legemiddel som inneholder 3-fenylsulfonyl-3,7-diazabisyklo[3,3,1Ånonan-forbindelser - Google Patents
Nytt legemiddel som inneholder 3-fenylsulfonyl-3,7-diazabisyklo[3,3,1Ånonan-forbindelserInfo
- Publication number
- NO950360L NO950360L NO950360A NO950360A NO950360L NO 950360 L NO950360 L NO 950360L NO 950360 A NO950360 A NO 950360A NO 950360 A NO950360 A NO 950360A NO 950360 L NO950360 L NO 950360L
- Authority
- NO
- Norway
- Prior art keywords
- diazabicyclo
- nonanone
- phenylsulfonyl
- compounds
- lower alkyl
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Anvendelse av 3,7,9,9-tetrasubsti- tuerte 3-fenylsulfonyl-3,7-diaza- bisyklo[3,3,1]nonanforbindelser til fremstilling av antiarytmisk aktive legemidler beskrives, og nye antiaryt- misk aktive 3,7,9,9-tetrasubstituerte forbindelser med den generelle formel la hvor R1 betyr en alkylgruppe med 1- 6 karbonatomer eller en sykloalkyl- alkylgruppe med 4-7 karbonatomer; R2 betyr lavere alkyl, og R3 betyr lavere alkyl; eller R2 og R3 danner til sammen en alkylenkjede med 3-6 karbonatomer; R4' står for cyan, for en R6-0-CO- gruppe, hvor R6 betyr lavere alkyl, for en R7-SO2-NH-gruppe, hvor R7 betyr lavere alkyl, eller for en R8-CO-NH- gruppe, hvor R8 betyr lavere alkyl eller en fenylgruppe, som eventuelt er substituert med halogen, cyan, nitro eller en R9-S02-rest, hvor R9 er lavere alkyl, eller for en imidazolylrest som er plassert i 4-stillingen i fenyl- ringen; og R5 betyr hydrogen eller halogen; og deres fysiologisk aksep- table syreaddisjonssalter, samt frem- gangsmåter og mellomprodukter for deres fremstilling er beskrevet.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4402931A DE4402931A1 (de) | 1994-02-01 | 1994-02-01 | Neue 3-Phenylsulfonyl-3,7-diazabicyclo[3,3,1] nonan-Verbindungen enthaltende Arzneimittel |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO950360D0 NO950360D0 (no) | 1995-01-31 |
| NO950360L true NO950360L (no) | 1995-08-02 |
Family
ID=6509146
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO950360A NO950360L (no) | 1994-02-01 | 1995-01-31 | Nytt legemiddel som inneholder 3-fenylsulfonyl-3,7-diazabisyklo[3,3,1Ånonan-forbindelser |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US5576327A (no) |
| EP (1) | EP0665228B1 (no) |
| JP (2) | JP3853389B2 (no) |
| KR (1) | KR100352899B1 (no) |
| CN (1) | CN1111631A (no) |
| AT (1) | ATE182149T1 (no) |
| AU (1) | AU1156495A (no) |
| CA (1) | CA2141366A1 (no) |
| CZ (1) | CZ25395A3 (no) |
| DE (2) | DE4402931A1 (no) |
| ES (1) | ES2133593T3 (no) |
| FI (1) | FI950422A (no) |
| HU (1) | HUT70174A (no) |
| IL (1) | IL112364A (no) |
| NO (1) | NO950360L (no) |
| NZ (1) | NZ270371A (no) |
| PL (1) | PL180075B1 (no) |
| RU (1) | RU95101437A (no) |
| SK (1) | SK11795A3 (no) |
| UA (1) | UA41329C2 (no) |
| ZA (1) | ZA95697B (no) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050004113A1 (en) * | 1999-06-16 | 2005-01-06 | Astrazeneca Ab | New bispidine compounds useful in the treatment of cardiac arrhythmias |
| SE9902270D0 (sv) | 1999-06-16 | 1999-06-16 | Astra Ab | Pharmaceutically active compounds |
| US20040229900A1 (en) * | 1999-06-16 | 2004-11-18 | Astrazeneca Ab | Bispidine compounds useful in the treatment of cardiac arrythmias |
| SE9904765D0 (sv) | 1999-12-23 | 1999-12-23 | Astra Ab | Pharmaceutically-useful compounds |
| AR030302A1 (es) * | 2000-07-07 | 2003-08-20 | Astrazeneca Ab | Compuestos de bispidina, formulacion farmaceutica, uso para la fabricacion de medicamentos, proceso para la preparacion de estos compuestos y compuestos intermediarios |
| US6808924B1 (en) | 2000-07-11 | 2004-10-26 | Claudia Lanari | Mouse mammary tumor lines expressing estrogen and progesterone receptors |
| SE0003795D0 (sv) | 2000-10-20 | 2000-10-20 | Astrazeneca Ab | Pharmaceutically useful compounds |
| SE0100326D0 (sv) | 2001-02-02 | 2001-02-02 | Astrazeneca Ab | New compounds |
| DE10131217A1 (de) | 2001-06-28 | 2003-01-09 | Solvay Pharm Gmbh | 3-Phenyl-3,7-diazabicyclo 3,3,1 nonan-Verbindungen sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |
| TW200418468A (en) * | 2002-11-18 | 2004-10-01 | Solvay Pharm Gmbh | Liquid pharmaceutical formulations containing 3,7-diazabicyclo[3,3,1]nonane compounds and method of treatments relating to anti-arrhytmic events |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3722134A1 (de) * | 1987-07-04 | 1989-01-19 | Kali Chemie Pharma Gmbh | 3-sulfonyl-3,7-diazabicyclo(3,3,1)nonan- verbindungen sowie verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
| US5153214A (en) * | 1989-06-28 | 1992-10-06 | Ciba-Geigy Corporation | Certain (arylsulfonamido- and imidazolyl-)-substituted carboxylic acids and derivatives thereof and use for suppressing thromboxane activity |
| US5110933A (en) * | 1989-11-13 | 1992-05-05 | Board Of Regents Of Oklahoma State University | Salts of 3-azabicyclo[3.3.1]nonanes as antiarrhythmic agents, and precursors thereof |
-
1994
- 1994-02-01 DE DE4402931A patent/DE4402931A1/de not_active Withdrawn
-
1995
- 1995-01-17 IL IL112364A patent/IL112364A/en not_active IP Right Cessation
- 1995-01-20 NZ NZ270371A patent/NZ270371A/en unknown
- 1995-01-25 ES ES95100954T patent/ES2133593T3/es not_active Expired - Lifetime
- 1995-01-25 EP EP95100954A patent/EP0665228B1/de not_active Expired - Lifetime
- 1995-01-25 AT AT95100954T patent/ATE182149T1/de not_active IP Right Cessation
- 1995-01-25 CN CN95101498A patent/CN1111631A/zh active Pending
- 1995-01-25 DE DE59506374T patent/DE59506374D1/de not_active Expired - Fee Related
- 1995-01-27 HU HU9500262A patent/HUT70174A/hu unknown
- 1995-01-28 KR KR1019950001749A patent/KR100352899B1/ko not_active IP Right Cessation
- 1995-01-30 AU AU11564/95A patent/AU1156495A/en not_active Abandoned
- 1995-01-30 CA CA002141366A patent/CA2141366A1/en not_active Abandoned
- 1995-01-30 ZA ZA95697A patent/ZA95697B/xx unknown
- 1995-01-30 PL PL95307000A patent/PL180075B1/pl not_active IP Right Cessation
- 1995-01-31 RU RU95101437/04A patent/RU95101437A/ru unknown
- 1995-01-31 FI FI950422A patent/FI950422A/fi not_active Application Discontinuation
- 1995-01-31 SK SK117-95A patent/SK11795A3/sk unknown
- 1995-01-31 NO NO950360A patent/NO950360L/no unknown
- 1995-01-31 UA UA95018090A patent/UA41329C2/uk unknown
- 1995-01-31 JP JP01420495A patent/JP3853389B2/ja not_active Expired - Fee Related
- 1995-02-01 US US08/382,262 patent/US5576327A/en not_active Expired - Fee Related
- 1995-02-01 CZ CZ95253A patent/CZ25395A3/cs unknown
-
1996
- 1996-01-31 US US08/594,946 patent/US5635511A/en not_active Expired - Lifetime
-
2005
- 2005-03-15 JP JP2005073660A patent/JP2005232179A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| JP2005232179A (ja) | 2005-09-02 |
| CN1111631A (zh) | 1995-11-15 |
| UA41329C2 (uk) | 2001-09-17 |
| CA2141366A1 (en) | 1995-08-02 |
| RU95101437A (ru) | 1996-10-27 |
| IL112364A0 (en) | 1995-03-30 |
| FI950422A (fi) | 1995-08-02 |
| FI950422A0 (fi) | 1995-01-31 |
| JPH07267954A (ja) | 1995-10-17 |
| EP0665228B1 (de) | 1999-07-14 |
| KR100352899B1 (ko) | 2003-02-05 |
| PL180075B1 (pl) | 2000-12-29 |
| ATE182149T1 (de) | 1999-07-15 |
| ZA95697B (en) | 1996-02-07 |
| US5635511A (en) | 1997-06-03 |
| NO950360D0 (no) | 1995-01-31 |
| IL112364A (en) | 1998-01-04 |
| DE59506374D1 (de) | 1999-08-19 |
| ES2133593T3 (es) | 1999-09-16 |
| HU9500262D0 (en) | 1995-03-28 |
| MX9500679A (es) | 1998-03-31 |
| SK11795A3 (en) | 1995-08-09 |
| NZ270371A (en) | 1997-02-24 |
| US5576327A (en) | 1996-11-19 |
| AU1156495A (en) | 1995-08-10 |
| JP3853389B2 (ja) | 2006-12-06 |
| CZ25395A3 (en) | 1995-10-18 |
| DE4402931A1 (de) | 1995-08-03 |
| PL307000A1 (en) | 1995-08-07 |
| HUT70174A (en) | 1995-09-28 |
| EP0665228A1 (de) | 1995-08-02 |
| KR950031075A (ko) | 1995-12-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU666702B2 (en) | Morphinan derivative and medicinal use | |
| NO2005004I1 (no) | Duloksetin og dets farmasøytisk akseptable syreaddisjonssalter, spesielt duloksetin hydroklorid | |
| ATE124405T1 (de) | 1,4,7,10-tetraazacyclododecan-butyltriole, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel. | |
| FI943142A (fi) | Amidi- ja ureajohdannaiset, joilla on veren korkeita kolesteroliarvoja vastustava vaikutus, niiden valmistus ja terapeuttiset käytöt | |
| DK232989D0 (da) | Antiviralt praeparat | |
| EP0550006A3 (en) | Use of n-acyl derivatives of aminoalcohols for the manufacture of a medicament for the treatment of pathologies involving mast cells | |
| NO950360L (no) | Nytt legemiddel som inneholder 3-fenylsulfonyl-3,7-diazabisyklo[3,3,1Ånonan-forbindelser | |
| FI924744A (fi) | Terapeutiska aemnen | |
| SE8600017D0 (sv) | New compound | |
| SE9300758D0 (sv) | Process for the production of clavulanic acid | |
| MY103210A (en) | Arylpiperazinyl-alkylene-phenyl-heterocyclic compounds. | |
| GB8823605D0 (en) | Therapeutic agents | |
| ATE125538T1 (de) | Thiochromanderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen. | |
| TW349864B (en) | Use of N-(pyridinyl)-1H-indol-a-amines for the preparation of a medicament for the treatment of obsessive-compulsive disorders | |
| NO950361L (no) | Nytt legemiddel som inneholder 3-benzoyl-3,7-diazabisyklo[3,3,1)nonan-forbindelser | |
| DE69105865D1 (de) | Biphenyl-5,5'-bis-Alkansäurederivate, deren Herstellung und Verwendung. | |
| FI921475A0 (fi) | 1,4-dihydro-4-oxo-3-kinolinderivat som selektivt toxiska antibakteriella aemenn hos daeggdjur. | |
| EP0447812A3 (en) | Use of a dihydropyridine to improve the inner ear blood circulation |